Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Abdominal recurrence after interventions on the intestines]

J R Siewert1, F T Huber, A Sendler

  • 1Chirurgische Klinik und Poliklinik, Technischen Universität München.

Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen
|October 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Gastric cancer and adenocarcinoma of the esophagogastric junction: principles of neoadjuvant therapy].

Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen·2011
Same author

[German S3-guideline "Diagnosis and treatment of esophagogastric cancer"].

Zeitschrift fur Gastroenterologie·2011
Same author

Metabolic response evaluation by PET during neoadjuvant treatment for adenocarcinoma of the esophagus and esophagogastric junction.

Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer·2010
Same author

Neoadjuvant treatment of adenocarcinomas of the gastroesophageal junction and stomach - a feasibility trial combining cisplatin and docetaxel with either 5-fluorouracil or capecitabine.

International journal of clinical pharmacology and therapeutics·2010
Same author

[Tumors of the upper gastro-intestinal tract].

Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen·2010
Same author

[Early Barrett's carcinoma/high grade intraepithelial neoplasia (HG-IEN): pro endoscopic treatment--pro surgical treatment].

Zeitschrift fur Gastroenterologie·2009
Same journal

[S3 Guideline "Adult soft tissue sarcomas"].

Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen·2022
Same journal

[Synopsis-S3 guidelines pancreatic cancer].

Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen·2022
Same journal

[Laparoscopic sentinel node navigation surgery in gastric cancer to reduce surgical radicality].

Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen·2022
Same journal

[Future concepts for neoadjuvant and adjuvant treatment of (resectable) pancreatic cancer].

Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen·2022
Same journal

[ASCO guidelines for the treatment of stage III NSCLC part 4: indications for adjuvant therapy].

Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen·2022
Same journal

[Surgical treatment of pancreatic cancer-What is new?]

Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen·2022
See all related articles

Local recurrences of intestinal tumors are categorized as intraluminal or extraluminal. Intraluminal recurrences offer a better prognosis and higher rates of successful reoperation for improved patient outcomes.

Area of Science:

  • Gastroenterology
  • Surgical Oncology
  • Oncology

Context:

  • Local recurrences (LR) of intestinal tumors necessitate classification into intra- and extraluminal types for surgical planning.
  • Esophageal cancer commonly recurs in the posterior mediastinum and neck, with limited curative reintervention options.
  • Gastric and colon cancers exhibit distinct recurrence patterns and resectability rates.

Purpose:

  • To differentiate the prognostic and therapeutic implications of intraluminal versus extraluminal local recurrences in intestinal malignancies.
  • To evaluate the feasibility and outcomes of operative reintervention for various types of local tumor recurrences.

Summary:

  • Local recurrences of intestinal tumors are classified as intraluminal or extraluminal, impacting reintervention possibilities.

Related Experiment Videos

  • Intraluminal recurrences, particularly in gastric and colon cancers, demonstrate a better prognosis and higher rates of successful curative resection.
  • While curative reresection is often unfeasible for esophageal cancer, it is achievable in a significant proportion of intraluminal gastric and colon cancer recurrences.

    • Impact:

    • Distinguishing between intraluminal and extraluminal recurrences aids in tailoring treatment strategies for intestinal tumors.
    • Identifying factors influencing resectability and R0-resection rates can optimize surgical decision-making for recurrent disease.
    • This classification improves the understanding of prognostic indicators for patients with local tumor recurrences, guiding palliative versus curative treatment approaches.